PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.73 | 5.46
Analyze analyst forecasts for the company and compare them with competitors.
17.29B
The estimated revenue has increased from the previous period.
9.00B
The estimated EBITDA has increased from the previous period.
5.53
The estimated EPS has increased from the previous period.
5.08B
The estimated net income has increased from the previous period.
7.82B
The estimated EBIT has increased from the previous period.
1.75B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
20.03B
Revenue has increased from the previous period.
9.18%
Revenue growth rate has decreased from the previous period.
11.22B
EBITDA has increased from the previous period.
56.05%
EBITDA margin has increased from the previous period.
10.25B
EBIT has increased from the previous period.
51.16%
EBIT margin has increased from the previous period.
979.00M
Depreciation has increased from the previous period.
9.07B
Total cash has decreased from the previous period.
45.27%
Cash percentage has decreased from the previous period.
1.90B
Receivables have increased from the previous period.
9.46%
Receivables percentage has increased from the previous period.
2.76B
Inventories have increased from the previous period.
13.77%
Inventory percentage has increased from the previous period.
851.00M
Accounts payable has increased from the previous period.
4.25%
Payables percentage has increased from the previous period.
-2.80B
Capital expenditure has increased from the previous period.
-13.97%
CapEx percentage has increased from the previous period.
8.58%
WACC is unchanged from the previous period.
8.89%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
0.98
Beta is unchanged from the previous period.
916.00M
Diluted shares outstanding is unchanged from the previous period.
11.22B
Total debt is unchanged from the previous period.
175.82B
Total equity is unchanged from the previous period.
187.04B
Total capital is unchanged from the previous period.
6.00%
Debt weighting is unchanged from the previous period.
94.00%
Equity weighting is unchanged from the previous period.
8.94B
EBIAT has increased from the previous period.
6.27B
UFCF has decreased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
172.18B
Terminal value is unchanged from the previous period.
141.75B
Enterprise value has decreased from the previous period.
8.26B
Net debt is unchanged from the previous period.
133.49B
Equity value has decreased from the previous period.
145.73
Equity value per share is unchanged from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$194.00
Analysts expect the stock price to decrease by 5.82%.
Buy
Positive consensus among analysts.